Cargando…

Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study

OBJECTIVE: To examine the association between hyperkalemia and long-term cardiovascular and renal outcomes in patients with chronic kidney disease. PATIENTS AND METHODS: An observational retrospective cohort study was performed using a Japanese hospital claims registry, Medical Data Vision (April 1,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohsaka, Shun, Okami, Suguru, Kanda, Eiichiro, Kashihara, Naoki, Yajima, Toshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105529/ https://www.ncbi.nlm.nih.gov/pubmed/33997627 http://dx.doi.org/10.1016/j.mayocpiqo.2020.10.001

Ejemplares similares

Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan
por: Kanda, Eiichiro, et al.
Publicado: (2020)

Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
por: Kashihara, Naoki, et al.
Publicado: (2019)

Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia
por: Kanda, Eiichiro, et al.
Publicado: (2022)

Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia
por: Kohsaka, Shun, et al.
Publicado: (2022)

Correction: Kohsaka et al. Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828
por: Kohsaka, Shun, et al.
Publicado: (2023)

Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study
por: Kanda, Eiichiro, et al.
Publicado: (2023)

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
por: Kanda, Eiichiro, et al.
Publicado: (2023)

eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
por: Itano, Seiji, et al.
Publicado: (2023)

Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality
por: Kanda, Eiichiro, et al.
Publicado: (2023)

A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
por: Kashihara, Naoki, et al.
Publicado: (2020)

Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study
por: Kashihara, Naoki, et al.
Publicado: (2020)

Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study
por: Kanda, Eiichiro, et al.
Publicado: (2017)

Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients
por: Iwagami, Masao, et al.
Publicado: (2023)

Chronic renal failure, hyperkalemia, and colonic ulcers
por: George, S. A., et al.
Publicado: (2014)

Observation period for changes in proteinuria and risk prediction of end‐stage renal disease in general population
por: Usui, Tomoko, et al.
Publicado: (2018)

Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study
por: Kanda, Eiichiro, et al.
Publicado: (2015)

Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
por: Calabrese, Vincenzo, et al.
Publicado: (2022)

Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
por: Khanagavi, Jagadish, et al.
Publicado: (2014)

Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes
por: Alrashidi, Tahani Nasser, et al.
Publicado: (2020)

Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease
por: Kim, Gheun-Ho
Publicado: (2019)

Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
por: Sarnowski, Alexander, et al.
Publicado: (2022)

Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort
por: Kanda, Eiichiro, et al.
Publicado: (2015)

Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
por: Yang, Chen-Ta, et al.
Publicado: (2018)

New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease
por: Esposito, Pasquale, et al.
Publicado: (2020)

Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease
por: Jo, Sang Min
Publicado: (2023)

Uric Acid Level Has a U-Shaped Association with Loss of Kidney Function in Healthy People: A Prospective Cohort Study
por: Kanda, Eiichiro, et al.
Publicado: (2015)

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
por: Birkeland, Kåre I., et al.
Publicado: (2020)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease
por: Santoro, Antonio, et al.
Publicado: (2021)

Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
por: Nakayama, Takashin, et al.
Publicado: (2023)

Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia
por: Cook, Erin E., et al.
Publicado: (2021)

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
por: Morales, Enrique, et al.
Publicado: (2021)

Hematochezia in a Patient with Renal Failure and Hyperkalemia
por: Meira, Tânia, et al.
Publicado: (2015)

Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)
por: Sofue, Tadashi, et al.
Publicado: (2020)

Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics
por: Weir, Matthew R., et al.
Publicado: (2017)

Predicting hyperkalemia in patients with advanced chronic kidney disease using the XGBoost model
por: Chang, Hsin-Hsiung, et al.
Publicado: (2023)

Recent Progresses in Non-Dialysis Chronic Kidney Disease Patients with Hyperkalemia: Outcomes and Therapeutic Strategies
por: Tian, Ruixue, et al.
Publicado: (2023)

New options for the management of chronic hyperkalemia
por: Fried, Linda, et al.
Publicado: (2017)

Hyperkalemia in chronic peritoneal dialysis patients
por: Elliott, Andrew B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3ioh2nnpebdbmslifom7mpei5